Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark C Genovese

Showing results (21-30 of 172) with videos related to

Pageof 18
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
Long-term safety of subcutaneous abatacept in rheumatoid arthritis: integrated analysis of clinical trial data representing more than four years of treatmentRieke Alten, Jeffrey Kaine, Edward Keystone, et al.
RMD Open|February 27, 2018
Response to baricitinib therapy in patients with rheumatoid arthritis with inadequate response to csDMARDs as a function of baseline characteristicsJoel M Kremer, Michael Schiff, David Muram, et al.
Rheumatology (Oxford, England)|April 19, 2021
Long-term safety and efficacy of sarilumab over 5 years in patients with rheumatoid arthritis refractory to TNF inhibitorsRoy Fleischmann, Mark C Genovese, Karina Maslova, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2015
VX-509 (Decernotinib), an Oral Selective JAK-3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid ArthritisMark C Genovese, Ronald F van Vollenhoven, César Pacheco-Tena, et al.
ACR Open Rheumatology|November 18, 2021
The Incidence, Prevalence, and Associated Costs of Anemia, Malignancy, Venous Thromboembolism, Major Adverse Cardiovascular Events, and Infections in Rheumatoid Arthritis Patients by Treatment History in the United StatesRobin K Dore, Jenya N Antonova, Chakkarin Burudpakdee, et al.
Journal of Biomedical Materials Research. Part A|January 25, 2005
Temporal effects of a COX-2-selective NSAID on bone ingrowthStuart B Goodman, Ting Ma, Lance Mitsunaga, et al.
Seminars in Arthritis and Rheumatism|December 7, 2019
TNF-alpha inhibition for the treatment of cardiac sarcoidosisMatthew C Baker, Khushboo Sheth, Ronald Witteles, et al.
Seminars in Arthritis and Rheumatism|June 26, 2021
Corrigendum to 'TNF-alpha inhibition for the treatment of cardiac sarcoidosis' seminars in arthritis and rheumatism. 2020 Jun;50(3):546-552Matthew C Baker, Khushboo Sheth, Ronald Witteles, et al.
Arthritis and Rheumatism|May 18, 2004
Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexateMark C Genovese, Stanley Cohen, Larry Moreland, et al.
Clinical and Diagnostic Laboratory Immunology|December 13, 2005
Computer-assisted pattern recognition of autoantibody resultsSteven R Binder, Mark C Genovese, Joan T Merrill, et al.
Pageof 18

Showing results (21-30 of 172) with videos related to

Sort By:
Pageof 18
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
Long-term safety of subcutaneous abatacept in rheumatoid arthritis: integrated analysis of clinical trial data representing more than four years of treatmentRieke Alten, Jeffrey Kaine, Edward Keystone, et al.
RMD Open|February 27, 2018
Response to baricitinib therapy in patients with rheumatoid arthritis with inadequate response to csDMARDs as a function of baseline characteristicsJoel M Kremer, Michael Schiff, David Muram, et al.
Rheumatology (Oxford, England)|April 19, 2021
Long-term safety and efficacy of sarilumab over 5 years in patients with rheumatoid arthritis refractory to TNF inhibitorsRoy Fleischmann, Mark C Genovese, Karina Maslova, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2015
VX-509 (Decernotinib), an Oral Selective JAK-3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid ArthritisMark C Genovese, Ronald F van Vollenhoven, César Pacheco-Tena, et al.
ACR Open Rheumatology|November 18, 2021
The Incidence, Prevalence, and Associated Costs of Anemia, Malignancy, Venous Thromboembolism, Major Adverse Cardiovascular Events, and Infections in Rheumatoid Arthritis Patients by Treatment History in the United StatesRobin K Dore, Jenya N Antonova, Chakkarin Burudpakdee, et al.
Journal of Biomedical Materials Research. Part A|January 25, 2005
Temporal effects of a COX-2-selective NSAID on bone ingrowthStuart B Goodman, Ting Ma, Lance Mitsunaga, et al.
Seminars in Arthritis and Rheumatism|December 7, 2019
TNF-alpha inhibition for the treatment of cardiac sarcoidosisMatthew C Baker, Khushboo Sheth, Ronald Witteles, et al.
Seminars in Arthritis and Rheumatism|June 26, 2021
Corrigendum to 'TNF-alpha inhibition for the treatment of cardiac sarcoidosis' seminars in arthritis and rheumatism. 2020 Jun;50(3):546-552Matthew C Baker, Khushboo Sheth, Ronald Witteles, et al.
Arthritis and Rheumatism|May 18, 2004
Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexateMark C Genovese, Stanley Cohen, Larry Moreland, et al.
Clinical and Diagnostic Laboratory Immunology|December 13, 2005
Computer-assisted pattern recognition of autoantibody resultsSteven R Binder, Mark C Genovese, Joan T Merrill, et al.
Pageof 18